SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-013930 to SMART FOR LIFE, INC. (SMFL) (CIK 0001851860)

SMART FOR LIFE, INC. (SMFL) (CIK 0001851860)
Date: Dec. 20, 2023 · CIK: 0001851860 · Accession: 0000000000-23-013930

AI Filing Summary & Sentiment

File numbers found in text: 333-276071

Date
December 20, 2023
Author
Not clearly detected
Form
UPLOAD
Company
SMART FOR LIFE, INC. (SMFL) (CIK 0001851860)

Letter

United States securities and exchange commission logo December 20, 2023 Darren Minton Chief Executive Officer Smart for Life, Inc. 990 S Rogers Circle, Suite 3 Boca Raton, FL 33487 Re:Smart for Life, Inc. Registration Statement on Form S-1 Filed December 15, 2023 File No. 333-276071 Dear Darren Minton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Louis A. Bevilacqua

Show Raw Text
United States securities and exchange commission logo
December 20, 2023
Darren Minton
Chief Executive Officer
Smart for Life, Inc.
990 S Rogers Circle, Suite 3
Boca Raton, FL 33487
Re:Smart for Life, Inc.
Registration Statement on Form S-1
Filed December 15, 2023
File No. 333-276071
Dear Darren Minton:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Louis A. Bevilacqua